ClinVar Miner

Submissions for variant NM_138694.4(PKHD1):c.6854G>A (p.Gly2285Glu)

gnomAD frequency: 0.00145  dbSNP: rs142526715
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 14
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Eurofins Ntd Llc (ga) RCV000224543 SCV000230603 uncertain significance not provided 2018-05-30 criteria provided, single submitter clinical testing
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics RCV000224543 SCV000280843 uncertain significance not provided 2015-02-11 criteria provided, single submitter clinical testing Converted during submission to Uncertain significance.
Fulgent Genetics, Fulgent Genetics RCV000765886 SCV000897293 uncertain significance Autosomal recessive polycystic kidney disease 2018-10-31 criteria provided, single submitter clinical testing
Invitae RCV000765886 SCV001000779 likely benign Autosomal recessive polycystic kidney disease 2024-01-29 criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV000765886 SCV001327412 likely benign Autosomal recessive polycystic kidney disease 2017-04-27 criteria provided, single submitter clinical testing This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign.
GeneDx RCV000224543 SCV001983334 uncertain significance not provided 2023-10-02 criteria provided, single submitter clinical testing In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 24109560, 29642553, 21228398, 15805161, 16523049)
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV002282003 SCV002571035 uncertain significance not specified 2022-07-12 criteria provided, single submitter clinical testing Variant summary: PKHD1 c.6854G>A (p.Gly2285Glu) results in a non-conservative amino acid change located in the right handed beta helix domain (IPR039448) of the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.0013 in 250680 control chromosomes (gnomAD and Sharp_2005). This frequency is not significantly higher than estimated for a pathogenic variant in PKHD1 causing Polycystic Kidney And Hepatic Disease (0.0013 vs 0.0071), allowing no conclusion about variant significance. c.6854G>A has been reported in the literature in the compound heterozygous state in an individual affected with a milder, predominant biliary phenotype of polycystic kidney disease (Adeva_2006). These data do not allow any conclusion about variant significance. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Eight submitters have provided clinical-significance assessments for this variant to ClinVar after 2014 with conflicting assessments (VUS n=5, likely benign n=3). Based on the evidence outlined above, the variant was classified as uncertain significance.
Mayo Clinic Laboratories, Mayo Clinic RCV000224543 SCV004227249 uncertain significance not provided 2022-10-04 criteria provided, single submitter clinical testing BP4
PreventionGenetics, part of Exact Sciences RCV003917663 SCV004733678 likely benign PKHD1-related condition 2023-09-15 criteria provided, single submitter clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).
Natera, Inc. RCV000765886 SCV001455258 uncertain significance Autosomal recessive polycystic kidney disease 2019-12-19 no assertion criteria provided clinical testing
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen RCV000224543 SCV001744038 likely benign not provided no assertion criteria provided clinical testing
Laboratory of Gastroenterology and Hepatology, Radboud University Medical Center RCV001844816 SCV001877013 likely benign Autosomal dominant polycystic liver disease 2021-09-01 no assertion criteria provided research
Genome Diagnostics Laboratory, University Medical Center Utrecht RCV000224543 SCV001932579 likely benign not provided no assertion criteria provided clinical testing
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center RCV000224543 SCV001969297 likely benign not provided no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.